Four of the (GALNTL6, TOMM40, TBC1D9, MMP16) “synaptic transmission” module genes had MAPT H2 non‐carrier, and the other two (CADM2, GABRG2) had H2 carrier–specific AD risk association (Table 2). This evidence concerns the gene MAPT and Alzheimer disease.